Long-term infliximab for severe hidradenitis suppurativa.
Thielen
A-M
AM
Barde
C
C
Saurat
J-H
JH
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001004:Anus Diseases / Q000188:drug therapy; D003879:Dermatologic Agents / Q000627:therapeutic use*; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab